Comparative efficacy of acupressure and magnetic therapy vs. diclofenac sodium for pain management in upper urinary tract calculi.

Researchers compared two approaches for managing severe kidney stone pain: acupressure combined with magnetic therapy (AMT) versus the common pain medication diclofenac sodium. The study involved 138 patients experiencing acute kidney stone pain with severity ratings of 7 or higher on a 10-point scale. Patients were randomly assigned to receive either AMT or diclofenac, and their pain levels were measured at multiple time points. The acupressure and magnetic therapy combination worked remarkably fast, reducing pain by 86% within just one minute of treatment. However, this relief was relatively short-lived, lasting about 2.4 hours on average before pain began returning after 30 minutes. In contrast, diclofenac took longer to start working but provided pain relief for much longer—approximately 23.6 hours. The study also found that treatment effectiveness varied based on patient characteristics: men and patients with lower white blood cell counts responded particularly well to the acupressure-magnetic therapy approach. These findings suggest that acupressure and magnetic therapy might be especially useful for patients seeking immediate pain relief from kidney stones, while medication provides longer-lasting comfort. The researchers propose that combining both approaches strategically could offer the best of both worlds—rapid initial relief followed by sustained pain control. For patients interested in acupuncture-based pain management, these results are encouraging, showing measurable and rapid effects for acute pain conditions. If you're considering acupuncture or acupressure for kidney stone pain or other conditions, seek treatment from a licensed acupuncturist with appropriate training and credentials.

This randomized trial (n=138) evaluated acupressure and magnetic therapy (AMT) versus diclofenac sodium (DFS) for acute renal colic management in patients with VAS scores ≥7. AMT demonstrated rapid onset analgesia with 86% VAS reduction at 1-minute post-intervention (P<0.001 vs. baseline), though pain rebound occurred after 30 minutes with mean analgesic duration of 2.4±1.0 hours. DFS exhibited slower onset but significantly prolonged duration (23.6±2.2 hours, P<0.001). Multiple linear regression analysis identified AMT as the superior analgesic modality at 10 minutes (B=-6.22, P<0.001). Male gender (B=0.78, P=0.026) and lower baseline WBC counts (B=-0.16, P=0.026) were associated with higher VAS scores. Interaction analysis revealed enhanced AMT efficacy in male patients and those with lower WBC counts. Clinical takeaway: AMT and DFS offer complementary rapid-sustained analgesic profiles, suggesting potential benefit from stratified treatment protocols incorporating patient gender and inflammatory markers to optimize acute renal colic management.